Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial-resistant pathogens in the 1990s

G A Jacoby1

  • 1Lahey Hitchcock Clinic, Burlington, Massachusetts 01805, USA.

Annual Review of Medicine
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States.

Antimicrobial agents and chemotherapy·2006
Same author

Broader distribution of plasmid-mediated quinolone resistance in the United States.

Antimicrobial agents and chemotherapy·2005
Same author

Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.

Antimicrobial agents and chemotherapy·2004
Same author

Epidemiology of extended-spectrum beta-lactamases in Sofia, Bulgaria.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2003
Same author

Evolution of TEM-related extended-spectrum beta-lactamases in Korea.

Antimicrobial agents and chemotherapy·2001
Same author

Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea.

Journal of clinical microbiology·2001
Same journal

Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis.

Annual review of medicine·2026
Same journal

CAR T Cell Toxicities and Emerging Treatment Strategies.

Annual review of medicine·2026
Same journal

Transthyretin Amyloid Cardiomyopathy: A Rapidly Evolving Landscape.

Annual review of medicine·2026
Same journal

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.

Annual review of medicine·2026
Same journal

Diffuse Parenchymal Lung Disease: Updates in Pathophysiology and Management.

Annual review of medicine·2026
Same journal

Revascularization for Ischemic Cardiomyopathy: Disproving the 45-Year-Old Concept of Hibernating Myocardium.

Annual review of medicine·2026
See all related articles

Antimicrobial resistance in Streptococcus pneumoniae, Enterococcus, Staphylococcus aureus, and Klebsiella pneumoniae is a growing concern. This review covers resistance epidemiology, detection, mechanisms, and management strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Common bacterial pathogens like Streptococcus pneumoniae, Enterococcus species, Staphylococcus aureus, and Klebsiella pneumoniae exhibit increasing resistance to antimicrobial drugs.
  • This rising antimicrobial resistance poses a significant threat to public health and effective treatment of infections.

Purpose of the Study:

  • To provide a comprehensive review of antimicrobial resistance in key bacterial pathogens.
  • To discuss the epidemiology, laboratory detection, resistance mechanisms, and therapeutic options for these resistant bacteria.

Main Methods:

  • Literature review of epidemiology, laboratory diagnostics, and mechanisms of antimicrobial resistance.
  • Analysis of current therapeutic strategies and infection control measures.

Related Experiment Videos

Main Results:

  • Detailed overview of the prevalence and spread of antimicrobial resistance in the specified pathogens.
  • Explanation of various laboratory methods for detecting resistance.
  • Elucidation of molecular mechanisms underlying antimicrobial resistance.
  • Summary of effective treatment options and infection control protocols.

Conclusions:

  • Effective management of infections caused by multidrug-resistant bacteria requires a thorough understanding of resistance patterns and mechanisms.
  • Integrated strategies involving diagnostics, therapy, and infection control are crucial to combat the growing threat of antimicrobial resistance.